跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CIMZIA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CIMZIA
Authorized
STANDARD
CIMZIA
UCB Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7d586043bfcfda3a
Company
UCB Canada Inc
Type
Standard
Approval Details
Approval Id
7d586043bfcfda3a
Drug Approval Canada Name
CIMZIA
Product Name
CIMZIA
Status
Marketed
Status Date
2017-08-04
Original Market Date
2017-08-04
Din
02465574
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
90:24.16.92
Atc Original
L04AB05 CERTOLIZUMAB PEGOL
Atc Name
l 04 ab 05
Aig Number
0152646001
Company Name
UCB Canada Inc
Company Address
602, 2201 Bristol Circle, Oakville, Ontario, Canada, L6H 0J8
Active Ingredients
CERTOLIZUMAB PEGOL
200 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7d586043bfcfda3a
Type
Standard
Back to Health Canada Approvals